| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |